Help Therapeutics
Nanjing
About Help Therapeutics
Founded in 2016, Help Therapeutics is a global clinical-stage biopharmaceutical company dedicated to establishing a State National iPS Cell Bank and developing first-in-class iPSC-derived cell therapeutics for patients with degenerative diseases. The company is committed to driving and empowering off-the-shelf cell therapy products in the fields of cardiac failure, other degenerative diseases, and oncology. At Help Therapeutics, we believe that providing superior development and manufacturing technologies, value, and support at every stage of the journey is the best way to deliver safe, effective, and revolutionary cell therapy products to patients in need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $25.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Dec 2025)
- Website: en.helptherapeutics.com
- Phone: +86 025 87177801
Industries & Categories
Biotechnology, Health Care, Market Research
Social Profiles
Canonical: https://fsome.com/organization/help-therapeutics-104309 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.